Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

about

Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.Microglia in Alzheimer's Disease: A Role for Ion Channels Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease

P2860

Q55262265-1E6DBF0B-BBFB-4315-A58F-A99F8F475B45 Q57490199-7E4697CC-9A7C-4F10-9536-25FB6F80CF9F Q57817388-0F68B7F9-4BBF-4D05-A8A7-BBD43FBF8C61

P2860

Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

Item

http://www.wikidata.org/entity/Q47258976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@en

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@nl

type

Item

label

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@en

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@nl

prefLabel

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@en

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@nl

P1476

Kv1.3 inhibition as a potentia ...... preclinical proof of concept.

@en

P2093

Allan I Levey

http://www.w3.org/2001/XMLSchema#string

David Paul Jenkins

http://www.w3.org/2001/XMLSchema#string

Hai M Nguyen

http://www.w3.org/2001/XMLSchema#string

Heike Wulff

http://www.w3.org/2001/XMLSchema#string

Izumi Maezawa

http://www.w3.org/2001/XMLSchema#string

Jacopo Di Lucente

http://www.w3.org/2001/XMLSchema#string

Kyoungmi Kim

http://www.w3.org/2001/XMLSchema#string

Lee-Way Jin

http://www.w3.org/2001/XMLSchema#string

Silvia Hilt

http://www.w3.org/2001/XMLSchema#string

Srikant Rangaraju

http://www.w3.org/2001/XMLSchema#string

P2860

Modulators of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels and their Therapeutic Indications

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block.

K+ channels as targets for specific immunomodulation

The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

The amyloid hypothesis of Alzheimer's disease at 25 years

Structural and functional features of central nervous system lymphatic vessels.

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

Neuroinflammation in Alzheimer's disease

P31

scholarly article

P356

10.1093/BRAIN/AWX346

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29272333

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

microglia

microglial inhibitor

P932

5837198

http://www.w3.org/2001/XMLSchema#string

Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

about

P2860

P2860

Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921

P932